BIRMINGHAM, Ala.--(BUSINESS WIRE)-- Atherotech Diagnostics Lab will attend the South Central Obstetrical & Gynecological Society (SCOGS) 52nd Annual Meeting held this week in Charlottesville, Va.

Heart disease has become the number one killer of men and women in the United States, killing more than 500,000 people each year. Being heart-healthy is priority one for many health-savvy women. But ...

VAP Test better than standard lipid profile at risk assessment, guiding treatment, improving CV outcomes and reducing costs for adult managed care cardiac patients BIRMINGHAM, Ala.--(BUSINESS WIRE)-- ...

BIRMINGHAM, Ala., July 21 Using the VAP Cholesterol Testfrom Atherotech, researchers have identified a link between adiponectin andheart disease progression. The information could help physicians ...

BIRMINGHAM, Ala., Feb. 6 Atherotech, Inc., acardio-diagnostic company, today announced that the largest private insurersin Arizona as well as Medicare, Medicaid and the Federal Employees ...

VAP(r) Cholesterol Test on exhibit at 2010 American Congress of Obstetricians and Gynecologists conference BIRMINGHAM, Ala. - October 12, 2010 - Metabolic syndrome and insulin resistance are fast ...

Patrick D. Mize, Ph.D., has been appointed as Vice President of Regulatory Affairs at Atherotech Diagnostics Lab. Dr. Mize comes to Atherotech with more than 30 years of experience in the chemical and ...

BIRMINGHAM, Ala. & WINSTON-SALEM, N.C.--(BUSINESS WIRE)--An industry-first collaboration is bringing together cardiovascular testing company Atherotech Diagnostics Lab (www.Atherotech.com) and ...

VAP Test better than standard lipid profile at risk assessment, guiding treatment, improving CV outcomes and reducing costs for adult managed care cardiac patients BIRMINGHAM, Ala.--(BUSINESS WIRE)-- ...

New clinical trial results demonstrated that using the VAP® (Vertical Auto Profile) comprehensive cholesterol test in a disease management program for cardiac patients resulted in better patient care ...